Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRESS LIMITED Director's Dealing 2018

Sep 16, 2018

65141_rns_2018-09-16_995bff4e-401c-4af7-81e9-0f91b27896c7.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [546 x 84] intentionally omitted <==

The Manager Company Announcements Office Australian Stock Exchange Exchange Centre 20 Bridge Street SYDNEY NSW 2000

17 September 2018

Dear Sir or Madam

RE: APPENDIX 3Y – ANDREW WALSH – CEO & MANAGING DIRECTOR

Please find attached an Appendix 3Y announcement relating to the sale of shares by Andrew Walsh, CEO & Managing Director. This transaction has been made to meet tax obligations arising on the vesting of equity-based remuneration and personal financial planning.

IRESS places critical importance on equity-based remuneration and meaningful ongoing exposure to equity in aligning the interests of employees with shareholders. As detailed in the 3Y, following this transaction Mr. Walsh retains 325,585 shares in the company (in direct and indirect holdings) and 159,369 unvested deferred share rights and general employee shares, representing multiples of fixed remuneration and meaningful exposure. In addition, Mr Walsh holds 566,688 unvested performance rights.

Yours sincerely

==> picture [156 x 67] intentionally omitted <==

Peter Ferguson Group General Counsel & Company Secretary

IRESS Limited T +61 3 9018 5800 Corporate Office: Level 18, 385 Bourke Street [email protected] MELBOURNE VIC 3000 Australia www.iress.com.au

Offices in : Australia, Canada, Hong Kong, New Zealand, Singapore, South Africa and United Kingdom

ABN: 47 060 313 359

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity IRESS Limited
ABN
47 060 313 359

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Andrew Walsh
Date of last notice 10 May 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Date of change 17 September 2018
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change Ordinary Shares
Direct:
435,266
Indirect:
44,909
Unvested Share/Rights Grants:
2014 Series
Performance Rights 2014:

4 year term, granted 7 May 2014, 3 year measurement
period commencing 7 May 2015: - 63,000

4 year term, granted 7 May 2014, 4 year measurement
period commencing 7 May 2014: - 63,000
2015 Series
Performance Rights 2015:

4 year term, granted 7 May 2015, 3 year measurement
period commencing 7 May 2016: - 60,000

4 year term, granted 7 May 2015, 4 year measurement
period commencing 7 May 2015: - 60,000
2016 Series
Deferred Shares Rights 2016:

3 year term granted 7 May 2016: - 60,000
Performance Rights 2016:

4 year term, granted 7 May 2016, 3 year measurement
period commencing 1 Jan 2017: - 60,000

4 year term, granted 7 May 2016, 4 year measurement
period commencing 1 Jan 2016: - 60,000
General Employee Shares 2016:

3 year term granted 22 Jul 2016: - 87
2017 Series
Deferred Shares Rights 2017:

3 year term: - 47,575
Performance Rights 2017:

4 year term, 3 year measurement period commencing
1 Jan 2018: - 54,739

4 year term, 4 year measurement period commencing
1 Jan 2017: - 54,739
2018 Series
Deferred Shares Rights 2018:

3 year term, granted 10 May 2018: - 51,707
Performance Rights 2018:

4 year term, granted 10 May 2018, 3 year measurement
period commencing 1 Jan 2019: - 45,605

4 year term, granted 10 May 2018, 4 year measurement
period commencing 1 Jan 2018: - 45,605
Class Ordinary
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Number acquired Nil
Number disposed 154,590
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Average price per share $12.98.
Total proceeds on sale $2,006,578
No. of securities held after change Ordinary Shares
Direct:
280,676
Indirect:
44,909
325,585
Unvested Share/Rights Grants Overview:
Deferred Shares and General Employee Shares
all Series:
159,369
Performance Rights all Series:
566,688
Unvested Share/Rights Grants Details:
2014 Series
Performance Rights 2014:

4 year term, granted 7 May 2014, 3 year measurement
period commencing 7 May 2015: - 63,000

4 year term, granted 7 May 2014, 4 year measurement
period commencing 7 May 2014: - 63,000
2015 Series
Performance Rights 2015:

4 year term, granted 7 May 2015, 3 year measurement
period commencing 7 May 2016: - 60,000

4 year term, granted 7 May 2015, 4 year measurement
period commencing 7 May 2015: - 60,000
2016 Series
Deferred Shares Rights 2016:

3 year term granted 7 May 2016: - 60,000
Performance Rights 2016:

4 year term, granted 7 May 2016, 3 year measurement
period commencing 1 Jan 2017: - 60,000

4 year term, granted 7 May 2016, 4 year measurement
period commencing 1 Jan 2016: - 60,000
General Employee Shares 2016:

3 year term granted 22 Jul 2016: - 87
2017 Series
Deferred Shares Rights 2017:

3 year term: - 47,575
Performance Rights 2017:
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

4 year term, 3 year measurement period commencing
1 Jan 2018: - 54,739
4 year term, 4 year measurement period commencing
1 Jan 2017: - 54,739
2018 Series
Deferred Shares Rights 2018:
3 year term, granted 10 May 2018: - 51,707
Performance Rights 2018:
4 year term, granted 10 May 2018, 3 year measurement
period commencing 1 Jan 2019: - 45,605
4 year term, granted 10 May 2018, 4 year measurement
period commencing 1 Jan 2018: - 45,605

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buyback

On market sale

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation to which the
interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated
valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

  • See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Were the interests in the securities or
contracts detailed above traded during a
+closed period where prior written
clearance was required?
No
If so, was prior written clearance
provided to allow the trade to proceed
during this period?
N/A
If prior written clearance was provided,
on what date was this provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 5